Literature DB >> 33768067

Clear Cell Carcinoma of the Thymus: An Improbable Enemy.

Fábio Rêgo Salgueiro1, Paulo Cunha2, Diana Miranda2, Tatiana Pereira1, Filipa Pontes1, Joana Monteiro1, Ana Caetano1.   

Abstract

INTRODUCTION: Thymic clear cell carcinoma is the most uncommon subtype of thymic carcinoma, with 20 cases reported worldwide. CASE DESCRIPTION: We present the case of a 61-year-old female with dyspnoea and chest pain for 2 days. Computed tomography (CT) angiography showed pulmonary thromboembolism and the existence of mediastinal and bilateral hilar lymphadenopathy, the largest infracarinal with an inferior axis of 25 mm, and also, micronodules on the left pulmonary parenchyma. The patient was admitted for aetiological assessment and underwent anticoagulant therapy. After a month, she had an ischaemic stroke, the sequelae of which proved to be fatal. The autopsy showed a mass in the superior-anterior mediastinum, with dimensions of 11×8×6 cm, corresponding to a thymus signet ring cell primary carcinoma. The immunohistochemistry study revealed that this mass was positive for AE1/AE3, CK5/6 and CK7.
CONCLUSION: The clinical, morphological and immunophenotypic diversity of this tumour makes its diagnosis a difficult multidisciplinary challenge, which requires a high level of clinical knowledge and accurate imaging and histological investigation. LEARNING POINTS: Thymic clear cell carcinoma is a very rare entity with an aggressive and nonspecific clinical behaviour.There are no defined diagnostic criteria, although diagnosis could be established with histologic/cytology analysis.There are no clear guidelines for treatment, which can include highly invasive surgery and chemotherapy or radiation therapy. © EFIM 2021.

Entities:  

Keywords:  Thymic carcinoma; mediastinal tumour

Year:  2021        PMID: 33768067      PMCID: PMC7977052          DOI: 10.12890/2021_002224

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  6 in total

1.  Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of Masaoka staging.

Authors:  Anya M Litvak; Kaitlin Woo; Sara Hayes; James Huang; Andreas Rimner; Camelia S Sima; Andre L Moreira; Maria Tsukazan; Gregory J Riely
Journal:  J Thorac Oncol       Date:  2014-12       Impact factor: 15.609

2.  The multimodality treatment of thymic carcinoma.

Authors:  M Lucchi; A Mussi; F Basolo; M C Ambrogi; G Fontanini; C A Angeletti
Journal:  Eur J Cardiothorac Surg       Date:  2001-05       Impact factor: 4.191

Review 3.  Thymic carcinoma: current concepts and histologic features.

Authors:  Cesar A Moran; Saul Suster
Journal:  Hematol Oncol Clin North Am       Date:  2008-06       Impact factor: 3.722

Review 4.  Carcinoma of the thymus with clear-cell features. Report of eight cases and review of the literature.

Authors:  R P Hasserjian; D S Klimstra; J Rosai
Journal:  Am J Surg Pathol       Date:  1995-07       Impact factor: 6.394

5.  Diagnosis of thymic clear cell carcinoma by cytology.

Authors:  Seema A Lale; Patricia G Tiscornia-Wasserman; Mohamed Aziz
Journal:  Case Rep Pathol       Date:  2013-09-23

6.  Primary clear cell carcinoma of the thymus and literature comparison of features.

Authors:  Xiaomin Dai; Li Zhao; Fang Peng
Journal:  Cancer Manag Res       Date:  2018-03-16       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.